• By ICR Secretariat
  • Posted Thursday, August 19, 2021

FDA OK's third dose of Moderna's COVID-19 vaccine for immunocompromised

http://www.pharmatimes.com/news/fda_oks_third_dose_of_moderna_covid-19_vaccine_for_immunocompromised_1374927

The US Food and Drug Administration (FDA) has approved an update to the emergency use authorisation for Moderna’s COVID-19 vaccine – mRNA-1273 – to include a third dose for immunocompromised individuals.